BlackRock Institutional Trust’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$204M Buy
1,420,538
+25,228
+2% +$3.62M 0.03% 573
2016
Q3
$165M Sell
1,395,310
-111,711
-7% -$13.2M 0.03% 631
2016
Q2
$160M Sell
1,507,021
-36,155
-2% -$3.83M 0.03% 635
2016
Q1
$172M Sell
1,543,176
-117,842
-7% -$13.1M 0.03% 616
2015
Q4
$260M Buy
1,661,018
+130,499
+9% +$20.4M 0.04% 435
2015
Q3
$201M Buy
1,530,519
+21,467
+1% +$2.82M 0.04% 521
2015
Q2
$263M Buy
1,509,052
+20,510
+1% +$3.57M 0.04% 435
2015
Q1
$257M Buy
1,488,542
+32,185
+2% +$5.55M 0.04% 465
2014
Q4
$189M Sell
1,456,357
-3,346
-0.2% -$433K 0.03% 569
2014
Q3
$188M Sell
1,459,703
-249,974
-15% -$32.2M 0.03% 540
2014
Q2
$151M Sell
1,709,677
-91,618
-5% -$8.11M 0.03% 670
2014
Q1
$169M Buy
1,801,295
+29,397
+2% +$2.76M 0.03% 600
2013
Q4
$200M Buy
1,771,898
+138,069
+8% +$15.6M 0.04% 498
2013
Q3
$129M Buy
1,633,829
+174,669
+12% +$13.8M 0.02% 652
2013
Q2
$96M Buy
+1,459,160
New +$96M 0.02% 773